Business Context and Reporting Period
Company: Bioaffinity Technologies, Inc. (BIAF)
Filing Type: Form 8-K (Current Report)
Date of Report: October 20, 2025
Reporting Period: Event-based report for October 20, 2025.
Business Context: The registrant is an emerging growth company incorporated in Delaware, trading on the Nasdaq Capital Market. The filing announces a scientific presentation at the CHEST 2025 annual meeting.
Key Financial Metrics
This Form 8-K filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is limited to reporting a specific corporate event.
Material Changes
No material financial changes or operational shifts are reported in this filing. The document solely discloses the scheduling of a research presentation.
Guidance, Outlook, and Management Commentary
- Event: The Company will present research at CHEST 2025, the annual meeting of the American College of Chest Physicians.
- Presenter: Rossella Titone, PhD, Project Manager for Product Development.
- Topic: "The Effect of Sputum Storage and Shipping Temperature on Flow Cytometric Outcomes of Sputum-Based Diagnostic Tests."
- Details: The poster presentation is scheduled for October 22, 2025, at 10:20 a.m. at poster board #4324.
- Exhibits: The press release and the research poster are attached as Exhibits 99.1 and 99.2.
Investor Verification Checklist
- Verify the content of the attached poster (Exhibit 99.2) to assess the clinical or technical significance of the sputum storage research.
- Confirm the attendance and presentation details at the CHEST 2025 meeting on October 22, 2025.
- Review the press release (Exhibit 99.1) for any additional context regarding the Company's product development pipeline.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial health metrics.